Clinical Trials Browser

Leukemia, Myeloid, Acute × oblimersen × Clear all

NCT00017589 2014-01-06

Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00004862 2013-02-01

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma